Parkinson's Spread Halted in Labs
Scientists at the University of Pennsylvania have made a groundbreaking discovery, identifying a brain immune protein called GPNMB that is crucial to the spread of Parkinson's disease. This exciting finding reveals that blocking GPNMB with antibodies successfully halted the toxic process between brain cells, offering a promising new avenue for developing treatments to slow the disease's progression.